Stummer, W.; Holling, M.; Bendok, B.R.; Vogelbaum, M.A.; Cox, A.; Renfrow, S.L.; Widhalm, G.; Ezrin, A.; DeSena, S.; Sackman, M.L.;
et al. The NXDC-MEN-301 Study on 5-ALA for Meningiomas Surgery: An Innovative Study Design for the Assessing the Benefit of Intra-Operative Fluorescence Imaging. Brain Sci. 2022, 12, 1044.
https://doi.org/10.3390/brainsci12081044
AMA Style
Stummer W, Holling M, Bendok BR, Vogelbaum MA, Cox A, Renfrow SL, Widhalm G, Ezrin A, DeSena S, Sackman ML,
et al. The NXDC-MEN-301 Study on 5-ALA for Meningiomas Surgery: An Innovative Study Design for the Assessing the Benefit of Intra-Operative Fluorescence Imaging. Brain Sciences. 2022; 12(8):1044.
https://doi.org/10.3390/brainsci12081044
Chicago/Turabian Style
Stummer, Walter, Markus Holling, Bernard R. Bendok, Michael A. Vogelbaum, Ashley Cox, Sara L. Renfrow, Georg Widhalm, Alan Ezrin, Salvatore DeSena, Murray L. Sackman,
and et al. 2022. "The NXDC-MEN-301 Study on 5-ALA for Meningiomas Surgery: An Innovative Study Design for the Assessing the Benefit of Intra-Operative Fluorescence Imaging" Brain Sciences 12, no. 8: 1044.
https://doi.org/10.3390/brainsci12081044
APA Style
Stummer, W., Holling, M., Bendok, B. R., Vogelbaum, M. A., Cox, A., Renfrow, S. L., Widhalm, G., Ezrin, A., DeSena, S., Sackman, M. L., & Wyse, J. W.
(2022). The NXDC-MEN-301 Study on 5-ALA for Meningiomas Surgery: An Innovative Study Design for the Assessing the Benefit of Intra-Operative Fluorescence Imaging. Brain Sciences, 12(8), 1044.
https://doi.org/10.3390/brainsci12081044
